113 related articles for article (PubMed ID: 10736424)
1. Metabolism and cytotoxic effects of 2-chloroadenine, the major catabolite of 2-chloro-2'-deoxyadenosine.
Bontemps F; Delacauw A; Cardoen S; Van Den Neste E; Van Den Berghe G
Biochem Pharmacol; 2000 May; 59(10):1237-43. PubMed ID: 10736424
[TBL] [Abstract][Full Text] [Related]
2. Resistance to 2-chloro-2'-deoxyadenosine of the human B-cell leukemia cell line EHEB.
Cardoen S; Van Den Neste E; Smal C; Rosier JF; Delacauw A; Ferrant A; Van den Berghe G; Bontemps F
Clin Cancer Res; 2001 Nov; 7(11):3559-66. PubMed ID: 11705877
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity and pharmacokinetics of cladribine metabolite, 2-chloroadenine in patients with leukemia.
Lindemalm S; Liliemark J; Juliusson G; Larsson R; Albertioni F
Cancer Lett; 2004 Jul; 210(2):171-7. PubMed ID: 15183532
[TBL] [Abstract][Full Text] [Related]
4. Stability and analysis of 2-chloro-2'-deoxyadenosine, 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine and 2-chloroadenine in human blood plasma.
Lindemalm S; Albertioni F; Liliemark J
Anticancer Drugs; 1997 Jun; 8(5):445-53. PubMed ID: 9215606
[TBL] [Abstract][Full Text] [Related]
5. Biochemical pharmacology and resistance to 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine, a novel analogue of cladribine in human leukemic cells.
Lotfi K; Månsson E; Spasokoukotskaja T; Pettersson B; Liliemark J; Peterson C; Eriksson S; Albertioni F
Clin Cancer Res; 1999 Sep; 5(9):2438-44. PubMed ID: 10499616
[TBL] [Abstract][Full Text] [Related]
6. Kinetics and metabolism of 2-chloro-2'-deoxyadenosine and 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine in the isolated perfused rat liver.
Albertioni F; Hassan M; Silberring J; Liliemark J
Eur J Drug Metab Pharmacokinet; 1995; 20(3):225-32. PubMed ID: 8751045
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological inhibition of the MAPK/ERK pathway increases sensitivity to 2-chloro-2'-deoxyadenosine (CdA) in the B-cell leukemia cell line EHEB.
Smal C; Lisart S; Maerevoet M; Ferrant A; Bontemps F; Van Den Neste E
Biochem Pharmacol; 2007 Feb; 73(3):351-8. PubMed ID: 17137556
[TBL] [Abstract][Full Text] [Related]
8. Comparison of cytotoxicity of 2-chloro- 2'-arabino-fluoro-2'-deoxyadenosine (clofarabine) with cladribine in mononuclear cells from patients with acute myeloid and chronic lymphocytic leukemia.
Lindemalm S; Liliemark J; Gruber A; Eriksson S; Karlsson MO; Wang Y; Albertioni F
Haematologica; 2003 Mar; 88(3):324-32. PubMed ID: 12651272
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of antitumor effects of cyclophosphamide derivatives in B-chronic lymphocytic leukemia cells by 2-chloro-2'-deoxyadenosine.
Van Den Neste E; Bontemps F; Delacauw A; Cardoen S; Louviaux I; Scheiff JM; Gillis E; Leveugle P; Deneys V; Ferrant A; Van den Berghe G
Leukemia; 1999 Jun; 13(6):918-25. PubMed ID: 10360381
[TBL] [Abstract][Full Text] [Related]
10. 2-Chloro-2'-deoxyadenosine inhibits DNA repair synthesis and potentiates UVC cytotoxicity in chronic lymphocytic leukemia B lymphocytes.
Van Den Neste E; Cardoen S; Husson B; Rosier JF; Delacauw A; Ferrant A; Van den Berghe G; Bontemps F
Leukemia; 2002 Jan; 16(1):36-43. PubMed ID: 11840261
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the ERK pathway promotes apoptosis induced by 2-chloro-2'-deoxyadenosine in the B-cell leukemia cell line EHEB.
Smal C; Lisart S; Ferrant A; Bontemps F; van den Neste E
Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1009-12. PubMed ID: 17065055
[TBL] [Abstract][Full Text] [Related]
12. Population Pharmacokinetics of Cladribine in Patients with Multiple Sclerosis.
Savic RM; Novakovic AM; Ekblom M; Munafo A; Karlsson MO
Clin Pharmacokinet; 2017 Oct; 56(10):1245-1253. PubMed ID: 28255849
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability and bacterial degradation of rectally administered 2-chloro-2'-deoxyadenosine.
Liliemark J; Albertioni F; Edlund C; Juliusson G
J Pharm Biomed Anal; 1995 Apr; 13(4-5):661-5. PubMed ID: 9696584
[TBL] [Abstract][Full Text] [Related]
14. Quantitation of synergism of arabinosylcytosine and cladribine against the growth of arabinosylcytosine-resistant human lymphoid cells.
Han T; Fernandez M; Chou TC; Agarwal RP
J Cancer Res Clin Oncol; 2005 Sep; 131(9):609-16. PubMed ID: 16044347
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of apoptosis induced in vitro by cladribine (2-CdA) combined with anthracyclines in lymphocytes from patients with B-cell chronic lymphocytic leukemia.
Szmigielska-Kaplon A; Smolewski P; Najder M; Robak T
Ann Hematol; 2002 Sep; 81(9):508-13. PubMed ID: 12373351
[TBL] [Abstract][Full Text] [Related]
16. Relationship between cladribine (CdA) plasma, intracellular CdA-5'-triphosphate (CdATP) concentration, deoxycytidine kinase (dCK), and chemotherapeutic activity in chronic lymphocytic leukemia (CLL).
Albertioni F; Lindemalm S; Eriksson S; Juliusson G; Liliemark J
Adv Exp Med Biol; 1998; 431():693-7. PubMed ID: 9598154
[TBL] [Abstract][Full Text] [Related]
17. 2-Chloro-2'-deoxyadenosine-induced apoptosis in T leukemia cells is mediated via a caspase-3-dependent mitochondrial feedback amplification loop.
Conrad DM; Robichaud MR; Mader JS; Boudreau RT; Richardson AM; Giacomantonio CA; Hoskin DW
Int J Oncol; 2008 Jun; 32(6):1325-33. PubMed ID: 18497995
[TBL] [Abstract][Full Text] [Related]
18. Effects of 2-chloro-2'-deoxyadenosine on the cell cycle in the human leukemia EHEB cell line.
Cardoen S; Van den Neste E; Smal C; Rosier JF; Ferrant A; Van den Berghe G; Bontemps F
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1425-9. PubMed ID: 15571271
[TBL] [Abstract][Full Text] [Related]
19. Determination of 2-chloro-2'-deoxyadenosine nucleotides in leukemic cells by ion-pair high-performance liquid chromatography.
Reichelova V; Albertioni F; Liliemark J
J Chromatogr B Biomed Appl; 1996 Jun; 682(1):115-23. PubMed ID: 8832432
[TBL] [Abstract][Full Text] [Related]
20. Comparison of antitumor activities of 2-chlorodeoxyadenosine and 9-beta-arabinosyl-2-fluoroadenine in chronic lymphocytic leukemia and marrow cells in vitro.
Begleiter A; Verburg L; Ashique A; Lee K; Israels LG; Mowat MR; Johnston JB
Leukemia; 1995 Nov; 9(11):1875-81. PubMed ID: 7475278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
